No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

byTeddy Guo

January 31, 2023

in StudyGraphics

Reading Time: 1 min read

Habitual social media use may alter neurodevelopment in adolescents

RelatedReports

Majority of pediatric medication-related visits to emergency department are preventable

Oncology

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

January 28, 2026

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Admission may not be needed following sleep apnea surgery

Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients

Mental health parity law associated with financial protection for children

Gender-affirming hormones improve psychosocial functioning in transgender youth

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports